Noninvasive assessment of coronary artery disease in diabetic patients: The role of stress echocardiography

Canadian Journal of Cardiology

Volumn 22, Issue SUPPL. A, 2006, Pages 26A-33A

  Hanzal, Djilali ^a   Ducharme, Anique ^a  

^a MONTREAL HEART INSTITUTE   (Canada)

Author keywords

Coronary artery disease; Diabetes evaluation; Stress echocardiography

Indexed keywords

ADENOSINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CAFFEINE; DIPYRIDAMOLE; DOBUTAMINE; THEOPHYLLINE;

CARDIOVASCULAR RISK; CLINICAL FEATURE; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORONARY ARTERY RECANALIZATION; DIABETES MELLITUS; DIABETIC PATIENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; DISEASE FREE SURVIVAL; EARLY DIAGNOSIS; EXERCISE ELECTROCARDIOGRAPHY; FALSE NEGATIVE RESULT; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HIGH RISK PATIENT; HUMAN; INTERMETHOD COMPARISON; MORTALITY; NON INVASIVE PROCEDURE; PATHOPHYSIOLOGY; PERCUTANEOUS CORONARY INTERVENTION; POPULATION RESEARCH; PRACTICE GUIDELINE; PREVALENCE; PROGNOSIS; REVIEW; RISK ASSESSMENT; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SILENT MYOCARDIAL ISCHEMIA; STRESS ECHOCARDIOGRAPHY; SURVIVAL RATE; UNITED STATES;

EID: 33845694642     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0828-282x(06)70976-x     Document Type: Review

References (74)

1. Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 1998;339:229-34.
2. Hammoud T, Tanguay JF, Bourassa MG. Management of coronary artery disease: Therapeutic options in patients with diabetes. J Am Coll Cardiol 2000;36:355-65.
3. Consensus development conference on the diagnosis of coronary heart disease in people with diabetes: 10-11 February 1998, Miami, Florida. American Diabetes Association. Diabetes Care 1998;21:1551-9.
4. Koistinen MJ. Prevalence of asymptomatic myocardial ischaemia in diabetic subjects. BMJ 1990;301:92-5.
5. Naka M, Hiramatsu K, Aizawa T, et al. Silent myocardial ischemia in patients with non-insulin-dependent diabetes mellitus as judged by treadmill exercise testing and coronary angiography. Am Heart J 1992;123:46-53.
6. Nesto RW, Phillips RT, Kett KG, et al. Angina and exertional myocardial ischemia in diabetic and nondiabetic patients: Assessment by exercise thallium scintigraphy. Ann Intern Med 1988;108:170-5.
7. Jacoby RM, Nesto RW. Acute myocardial infarction in the diabetic patient: Pathophysiology, clinical course and prognosis. J Am Coll Cardiol 1992;20:736-44.
8. Mulcahy D, Keegan J, Crean P, et al. Silent myocardial ischaemia in chronic stable angina: A study of its frequency and characteristics in 150 patients. Br Heart J 1988;60:417-23.
9. Cohn PF, Fox KM, Daly C. Silent myocardial ischemia. Circulation 2003;108:1263-77.
10. Sheps DS, McMahon RP, Light KC, et al. Low hot pain threshold predicts shorter time to exercise-induced angina: Results from the psychophysiological investigations of myocardial ischemia (PIMI) study. J Am Coll Cardiol 1999;33:1855-62.
11. American Diabetes Association. Standards of Medical Care in Diabetes. Diabetes Care 2005;28(Suppl 1):S4-36.
12. Clarkson P, Celermajer DS, Donald AE, et al. Impaired vascular reactivity in insulin-dependent diabetes mellitus is related to disease duration and low density lipoprotein cholesterol levels. J Am Coll Cardiol 1996;28:573-9.
13. Kannel WB, McGee DL. Diabetes and glucose tolerance as risk factors for cardiovascular disease: The Framingham study. Diabetes Care 1979;2:120-6.
14. Stamler J, Vaccaro O, Neaton JD, Wentworth D. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 1993;16:434-44.
15. Kannel WB, McGee DL. Diabetes and cardiovascular risk factors: The Framingham study. Circulation 1979;59:8-13.
16. Dinneen SF, Gerstein HC. The association of microalbuminuria and mortality in non-insulin-dependent diabetes mellitus. A systematic overview of the literature. Arch Intern Med 1997;157:1413-8.
17. Manske CL, Wilson RF, Wang Y, Thomas W. Prevalence of, and risk factors for, angiographically determined coronary artery disease in type I-diabetic patients with nephropathy. Arch Intern Med 1992;152:2450-5.
18. Borch-Johnsen K, Kreiner S. Proteinuria: Value as predictor of cardiovascular mortality in insulin dependent diabetes mellitus. Br Med J (Clin Res Ed) 1987;294:1651-4.
19. Janka HU. Increased cardiovascular morbidity and mortality in diabetes mellitus: Identification of the high risk patient. Diabetes Res Clin Pract 1996;30(Suppl):85-8.
20. Miettinen H, Lehto S, Salomaa V, et al. Impact of diabetes on mortality after the first myocardial infarction. The FINMONICA Myocardial Infarction Register Study Group. Diabetes Care 1998;21:69-75.
21. Zuanetti G, Latini R, Neilson JM, Schwartz PJ, Ewing DJ. Heart rate variability in patients with ventricular arrhythmias: Effect of antiarrhythmic drugs. Antiarrhythmic Drug Evaluation Group (ADEG). J Am Coll Cardiol 1991;17:604-12.
22. Orlander PR, Goff DC, Morrissey M, et al. The relation of diabetes to the severity of acute myocardial infarction and post-myocardial infarction survival in Mexican-Americans and non-Hispanic whites. The Corpus Christi Heart Project. Diabetes 1994;43:897-902.
23. Stein B, Weintraub WS, Gebhart SP, et al. Influence of diabetes mellitus on early and late outcome after percutaneous transluminal coronary angioplasty. Circulation 1995;91:979-89.
24. Giri S, Shaw LJ, Murthy DR, et al. Impact of diabetes on the risk stratification using stress single-photon emission computed tomography myocardial perfusion imaging in patients with symptoms suggestive of coronary artery disease. Circulation 2002;105:32-40.
25. Sniderman A, Michel C, Racine N. Heart disease in patients with diabetes mellitus. J Clin Epidemiol 1992;45:1357-70.
26. Gu K, Cowie CC, Harris MI. Diabetes and decline in heart disease mortality in US adults. JAMA 1999;281:1291-7.
27. Kang X, Berman DS, Lewin HC, et al. Incremental prognostic value of myocardial perfusion single photon emission computed tomography in patients with diabetes mellitus. Am Heart J 1999;138:1025-32.
28. Marwick TH, Case C, Sawada S, Vasey C, Short L, Lauer M. Use of stress echocardiography to predict mortality in patients with diabetes and known or suspected coronary artery disease. Diabetes Care 2002;25:1042-8.
29. Simonson JS, Schiller NB. Descent of the base of the left ventricle: An echocardiographic index of left ventricular function. J Am Soc Echocardiogr 1989;2:25-35.
30. Bruce RA, Hossack KF, DeRouen TA, Hofer V. Enhanced risk assessment for primary coronary heart disease events by maximal exercise testing: 10 years' experience of Seattle Heart Watch. J Am Coll Cardiol 1983;2:565-73.
31. Anderson KM, Wilson PW, Odell PM, Kannel WB. An updated coronary risk profile. A statement for health professionals. Circulation 1991;83:356-62.
32. Weiner DA, Ryan TJ, Parsons L, et al. Significance of silent myocardial ischemia during exercise testing in patients with diabetes mellitus: A report from the Coronary Artery Surgery Study (CASS) Registry. Am J Cardiol 1991;68:729-34.
33. Gibbons RJ, Balady GJ, Bricker JT, et al. ACC/AHA 2002 guideline update for exercise testing: Summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines). J Am Coll Cardiol 2002;40:1531-40.
34. Vanzetto G, Halimi S, Hammoud T, et al. Prediction of cardiovascular events in clinically selected high-risk NIDDM patients. Prognostic value of exercise stress test and thallium-201 single-photon emission computed tomography. Diabetes Care 1999;22:19-26.
35. Picano E, Sicari R, Varga A. Dipyridamole stress echocardiography. Cardiol Clin 1999;17:481-99.
36. Tavel ME. Stress testing in cardiac evaluation: Current concepts with emphasis on the ECG. Chest 2001;119:907-25.
37. Ryan T, Armstrong WF, O'Donnell JA, Feigenbaum H. Risk stratification after acute myocardial infarction by means of exercise two-dimensional echocardiography. Am Heart J 1987;114:1305-16.
38. Gottdiener JS. Overview of stress echocardiography: Uses, advantages, and limitations. Prog Cardiovasc Dis 2001;43:315-34.
39. Berning J, Steensgaard-Hansen F. Early estimation of risk by echocardiographic determination of wall motion index in an unselected population with acute myocardial infarction. Am J Cardiol 1990;65:567-76.
40. Bednarz J, Vignon P, Mor-Avi V, et al. Color kinesis: Principles of operation and technical guidelines. Echocardiography 1998;15:21-34.
41. Mor-Avi V, Vignon P, Koch R, et al. Segmental analysis of color kinesis images: New method for quantification of the magnitude and timing of endocardial motion during left ventricular systole and diastole. Circulation 1997;95:2082-97.
42. Schiller NB, Shah PM, Crawford M, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 1989;2:358-67.
43. Iliceto S, Galiuto L, Marangelli V, Rizzon P. Clinical use of stress echocardiography: factors affecting diagnostic accuracy. Eur Heart J 1994;15:672-80.
44. Al Mansour HA, Mulvagh SL, Pumper GM, Klarich KW, Foley DA. Usefulness of harmonic imaging for left ventricular opacification and endocardial border delineation by optison. Am J Cardiol 2000;85:795-9.
45. Malhotra V, Nwogu J, Bondmass MD, et al. Is the technically limited echocardiographic study an endangered species? Endocardial border definition with native tissue harmonic imaging and Optison contrast: A review of 200 cases. J Am Soc Echocardiogr 2000;13:771-3.
46. Thomson HL, Basmadjian AJ, Rainbird AJ, et al. Contrast echocardiography improves the accuracy and reproducibility of left ventricular remodeling measurements: A prospective, randomly assigned, blinded study. J Am Coll Cardiol 2001;38:867-75.
47. Rainbird AJ, Mulvagh SL, Oh JK, et al. Contrast dobutamine stress echocardiography: Clinical practice assessment in 300 consecutive patients. J Am Soc Echocardiogr 2001;14:378-85.
48. Thanigaraj S, Nease RF Jr, Schechtman KB, Wade RL, Loslo S, Perez JE. Use of contrast for image enhancement during stress echocardiography is cost-effective and reduces additional diagnostic testing. Am J Cardiol 2001;87:1430-2.
49. Fernandes LP, Tardif J-C, Arsenault A, et al. Detection of myocardial perfusion abnormalities after a recent acute coronary syndrome by quantitative Levovist myocardial contrast echocardiography: Comparison with 99m Tc-Myoview SPECT imaging. Can J Cardiol 2003;19:251-6.
50. Naqvi TZ. Recent advances in echocardiography. Expert Rev Cardiovasc Ther 2004;2:89-96.
51. Sytkowski PA, Kannel WB, D'Agostino RB. Changes in risk factors and the decline in mortality from cardiovascular disease. The Framingham Heart Study. N Engl J Med 1990;322:1635-41.
52. Elhendy A, Arruda AM, Mahoney DW, Pellikka PA. Prognostic stratification of diabetic patients by exercise echocardiography. J Am Coll Cardiol 2001;37:1551-7.
53. Krivokapich J, Child JS, Walter DO, Garfinkel A. Prognostic value of dobutamine stress echocardiography in predicting cardiac events in patients with known or suspected coronary artery disease. J Am Coll Cardiol 1999;33:708-16.
54. Severino S, Dandrea A, Caso P, et al. Long-term prognostic value of dipyridamole and dobutamine stress echocardiography in patients with known or suspected coronary artery disease. Ital Heart J 2001;2:256-64.
55. Chuah SC, Pellikka PA, Roger VL, McCully RB, Seward JB. Role of dobutamine stress echocardiography in predicting outcome in 860 patients with known or suspected coronary artery disease. Circulation 1998;97:1474-80.
56. Smart SC, Dionisopoulos PN, Knickelbine TA, Schuchard T, Sagar KB. Dobutamine-atropine stress echocardiography for risk stratification in patients with chronic left ventricular dysfunction. J Am Coll Cardiol 1999;33:512-21.
57. Ling LH, Pellikka PA, Mahoney DW, et al. Atropine augmentation in dobutamine stress echocardiography: Role and incremental value in a clinical practice setting. J Am Coll Cardiol 1996;28:551-7.
58. Picano E. Stress echocardiography. Expert Rev Cardiovasc Ther 2004;2:77-88.
59. Mertes H, Sawada SG, Ryan T, et al. Symptoms, adverse effects, and complications associated with dobutamine stress echocardiography. Experience in 1118 patients. Circulation 1993;88:15-9.
60. Bigi R, Desideri A, Cortigiani L, Bax JJ, Celegon L, Fiorentini C. Stress echocardiography for risk stratification of diabetic patients with known or suspected coronary artery disease. Diabetes Care 2001;24:1596-601.
61. Previtali M, Fetiveau R, Lanzarini L, Cavalotti C, Klersy C. Prognostic value of myocardial viability and ischemia detected by dobutamine stress echocardiography early after acute myocardial infarction treated with thrombolysis. J Am Coll Cardiol 1998;32:380-6.
62. La Canna G, Alfieri O, Giubbini R, Gargano M, Ferrari R, Visioli O. Echocardiography during infusion of dobutamine for identification of reversibly dysfunction in patients with chronic coronary artery disease. J Am Coll Cardiol 1994;23:617-26.
63. Severi S, Underwood R, Mohiaddin RH, Boyd H, Paterni M, Camici PG. Dobutamine stress: Effects on regional myocardial blood flow and wall motion. J Am Coll Cardiol 1995;26:1187-95.
64. Beller GA. Assessment of myocardial viability. Curr Opin Cardiol 1997;12:459-67.
65. Geleijnse ML, Fioretti PM, Roelandt JR. Methodology, feasibility, safety and diagnostic accuracy of dobutamine stress echocardiography. J Am Coll Cardiol 1997;30:595-606.
66. Schinkel AF, Bax JJ, Elhendy A, et al. Long-term prognostic value of dobutamine stress echocardiography compared with myocardial perfusion scanning in patients unable to perform exercise tests. Am J Med 2004;117:1-9.
67. Beanlands RS, Hendry PJ, Masters RG, deKemp RA, Woodend K, Ruddy TD. Delay in revascularization is associated with increased mortality rate in patients with severe left ventricular dysfunction and viable myocardium on fluorine 18-fluorodeoxyglucose positron emission tomography imaging. Circulation 1998;98(19 Suppi):II51-6.
68. Bates JR, Sawada SG, Segar DS, et al. Evaluation using dobutamine stress echocardiography in patients with insulin-dependent diabetes mellitus before kidney and/or pancreas transplantation. Am J Cardiol 1996;77:175-9.
69. Elhendy A, van Domburg RT, Poldermans D, et al. Safety and feasibility of dobutamine-atropine stress echocardiography for the diagnosis of coronary artery disease in diabetic patients unable to perform an exercise stress test. Diabetes Care 1998;21:1797-802.
70. Dhond MR, Donnell K, Singh S, et al. Value of negative dobutamine stress echocardiography in predicting long-term cardiac events. J Am Soc Echocardiogr 1999;12:471-5.
71. Marcovitz PA, Shayna V, Horn RA, Hepner A, Armstrong WF. Value of dobutamine stress echocardiography in determining the prognosis of patients with known or suspected coronary artery disease. Am J Cardiol 1996;78:404-8.
72. Kamalesh M, Matorin R, Sawada S. Prognostic value of a negative stress echocardiographic study in diabetic patients. Am Heart J 2002;143:163-8.
73. Zabalgoitia M, Ismaeil M. Diagnostic and prognostic use of stress echo in acute coronary syndromes including emergency department imaging. Echocardiography 2000;17:479-93.
74. Cerqueira MD, Weissman NJ, Dilsizian V, et al; American Heart Association Writing Group on Myocardial Segmentation and Registration for Cardiac Imaging. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation 2002;105:539-42.